Arylalkylamine compounds for use in the prevention or treatment of cancer
作者： Péter Ferdinandy , József Knoll , Ildikó Miklya , Zsuzsanna Schaff , Dezső Schuler
DOI:
关键词:
摘要: The invention relates to the field of prevention and treatment cancer, in particular suppression tumor manifestation. also compounds for use this field. A novel tumour manifestation (TMS) regulation a mammalian brain is recognized. compounds, pharmaceutical preparations, medicaments based on said TMS as well methods same.
lens.org 参考文章(45)
R.G. Jordens, M.D. Berry, C. Gillott, A.A. Boulton, Prolongation of life in an experimental model of aging in Drosophila melanogaster. Neurochemical Research. ,vol. 24, pp. 227- 233 ,(1999) , 10.1023/A:1022510004220
H.-J. Freisleben, F. Lehr, J. Fuchs, Lifespan of immunosuppressed NMRI-mice is increased by deprenyl Amine Oxidases: Function and Dysfunction. ,vol. 41, pp. 231- 236 ,(1994) , 10.1007/978-3-7091-9324-2_29
Joseph Knoll, How Selegiline ((-)-Deprenyl) Slows Brain Aging ,(2012)
Bogdan Z. Olenyuk, Leland Chung, Haiyen E. Zhau, Jean C. Shih, Boyang Jason Wu, Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer ,(2012)
Antal Simay, Károly Mozsolits, Eva Szinnyei, József Knoll, János Bergmann, Eva Somfai, Zoltán Török, New psychostimulant agent ,(1987)
William G. Tatton, Deprenyl compounds for treatment of glaucoma ,(1996)
J. Knoll, Antiaging Compounds: (-)Deprenyl (Selegiline) and (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a Selective Highly Potent Enhancer of the Impulse Propagation Mediated Release of Catecholamines and Serotonin in the Brain Cns Drug Reviews. ,vol. 7, pp. 317- 345 ,(2006) , 10.1111/J.1527-3458.2001.TB00202.X
Frank Telang, Colleen Shea, Youwen Xu, Lisa Muench, Joanna S Fowler, Jean Logan, Nora D Volkow, Elena Shumay, Fred McCall-Perez, Millard Jayne, Gene-Jack Wang, David L Alexoff, Karen Apelskog-Torres, Barbara Hubbard, Pauline Carter, Payton King, Stanley Fahn, Michelle Gilmor, Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain. Neuropsychopharmacology. ,vol. 40, pp. 650- 657 ,(2015) , 10.1038/NPP.2014.214
K. Kitani, S. Kanai, Y. Sato, M. Ohta, G.O. Ivy, M-C. Carrillo, Chronic treatment of (-)deprenyl prolongs the life span of male fischer 344 rats. Further evidence Life Sciences. ,vol. 52, pp. 281- 288 ,(1993) , 10.1016/0024-3205(93)90219-S
J. Knoll, T.T. Yen, I. Miklya, Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference. Life Sciences. ,vol. 54, pp. 1047- 1057 ,(1994) , 10.1016/0024-3205(94)00415-3